| Board Name | Posts By Drakon642 | Post Created | 
|---|---|---|
| IPIX Innovation Pharmaceuticals Inc | Again, NEVER said ALL THE VOLUME, w | 06/14/2017 11:32:19 AM | 
| IPIX Innovation Pharmaceuticals Inc | Sorry it took so long to respond, F  (1) | 06/14/2017 10:52:37 AM | 
| IPIX Innovation Pharmaceuticals Inc | From my observations my guess a hed  (2) | 06/13/2017 5:43:25 AM | 
| IPIX Innovation Pharmaceuticals Inc | I have ameritrade; mine appeared a | 06/12/2017 12:28:08 AM | 
| IPIX Innovation Pharmaceuticals Inc | New Brilacidin blog on $Ctix site:  (7) | 05/21/2017 6:30:38 PM | 
| IPIX Innovation Pharmaceuticals Inc | I completely agree and think they m | 05/06/2017 7:25:05 PM | 
| USMJ North American Cannabis Holdings, Inc. | Couldn't agree more!!! | 09/09/2015 2:34:26 AM | 
| USMJ North American Cannabis Holdings, Inc. | you had to buy yesterday to qualify | 07/30/2015 12:36:59 PM | 
| FWDG FutureWorld Corp | I'd consider anything above 2.00 a | 07/30/2015 3:41:19 AM | 
Recent Articles
- Grupo Aeroportuario del Pacifico's Operations Update After Hurricane
- Incredible Growth: The Journey of Netflix Investments
- Understanding the P/E Ratio for CommScope Holdings
- Transforming Rental Housing: Canadian Commitment to Affordability
- Important Update on Data Security from Langdon & Emison LLC
- Join the Battle: Investors Unite Against Molina Healthcare Fraud
- PRFoods Reports Successful Transition with Improved Financials
- Discover the Growth of $1000 in Green Brick Partners Today
- Crown Racing Competes in Radical World Finals at VIR
- Imperial Metals Efficiently Settles Unsecured Debentures
- Dynamix Corporation III's Successful IPO: A Fresh Beginning
- Knight Therapeutics Secures $100 Million Credit Facility
- Consolidated Lithium Metals Strengthens Financing Strategy
- Aventis Energy Completes Significant Financing for Growth
- Gran Tierra Energy's Strategic Confirmation on i3 Energy Acquisition
- KBR Investors: Key Actions Ahead of Securities Class Action Deadline
- Understanding Ten Years of Investment Growth in Stryker Corp
- Investors Urged to Act: Important Class Action Info for JSPR
- SohoMD Seeks Investment to Enhance Mental Health Services
- Gran Tierra Energy Updates Investors on i3 Acquisition Status
- Caliber Announces Innovative Debt-to-Equity Conversion Efforts
- Summit Hotel Properties Announces Strong Dividend Payments
- AeroVironment Investment Growth: A Decade of Success
- MoonLake Immunotherapeutics Class Action Details and Impacts
- Springview Holdings Ltd's Appeal Against Nasdaq Delisting Notice
- Serena Neel Unveils Exciting Holiday Bathroom Series on TikTok
- A Deep Dive Into Royal Caribbean Group's Long-Term Stock Growth
- Knight Therapeutics Secures $100M Credit Facility for Growth
- Understanding Nutanix's Stock Valuation Through P/E Ratio
- Aventis Energy Closes Flow-Through Financing for Growth!
- Lennar Corporation Extends Exchange Offer Deadline for Shares
- Bakkt Transitions Board Leadership to Propel Future Growth
- FibroBiologics Focuses on Innovative Treatments for Chronic Diseases
- Lundin Gold Updates on Share Capital and Voting Rights Status
- Cellectis Sets Eye on Third Quarter Results Release
- Unitil Expands Footprint with Acquisition of Maine Natural Gas
- Lucas GC Limited: Strong Financial Performance in 2025
- TWC Enterprises Limited's Third Quarter Overview and Dividend Update
- Lucas GC Limited's Financial Growth and Strategic Outlook
- Skyharbour Resources Highlights Participation in Mining Showcase
- MagnaChip Semiconductor's Earnings Outlook: Investor Insights
- TWC Enterprises Reports Strong Q3 2025 Results and Dividend
- Insights on Reed's Upcoming Earnings and Stock Performance
- Colabor Group: Leadership Changes Enhance Corporate Governance
- TrueBlue's Upcoming Earnings Report: What Investors Should Know
- Imperial Metals Completes Full Repayment of Debentures
- PLAYSTUDIOS Earnings Preview: Investors Watch Closely
- Dynamix Corporation III Successfully Launches IPO Raising $201.25 Million
- Upcoming Earnings: Insights into Biodesix's Financial Outlook
- Karyopharm Therapeutics: Earnings Speculation Ahead




